Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning

MeSH terms

• Adolescent
• Alemtuzumab
• Antibodies, Monoclonal / pharmacology
• Antibodies, Monoclonal, Humanized
• Antibodies, Neoplasm / pharmacology
• Antilymphocyte Serum / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Busulfan / administration & dosage
• Combined Modality Therapy
• Disease-Free Survival
• Female
• Graft vs Host Disease / epidemiology
• Graft vs Host Disease / etiology
• Graft vs Leukemia Effect*
• Hematopoietic Stem Cell Transplantation* / statistics & numerical data
• Humans
• Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
• Leukemia, Lymphocytic, Chronic, B-Cell / surgery*
• Lymphocyte Depletion
• Lymphocyte Transfusion*
• Male
• Middle Aged
• Survival Rate
• Transplantation Conditioning / methods*
• Transplantation, Homologous
• Vidarabine / administration & dosage
• Vidarabine / analogs & derivatives